Navigation Links
Malaria drug slows pancreatic cancer growth in mouse models
Date:3/15/2011

se models human pancreatic cancer cells placed under the rodents' skin (xenografts); human cells injected into the animals' pancreases (orthotopic transplants); and a genetic model (mice bioengineered to develop native pancreatic tumors).

The response to chloroquine was "profound" in the xenograft models, Kimmelman said: All eight untreated mice died of their cancer within 140 days, while only one of eight treated mice had died by 180 days.

The drug's effects were less dramatic but still impressive in the orthotopic and genetic mouse models, the researchers said. The tumors that developed in the genetically pancreatic cancer-prone mice were, like their equivalent in human patients, extremely resistant to all treatments. Among other properties, these tumors were embedded in tough, fibrous tissue that is difficult for drugs to penetrate.

Nevertheless, the scientists reported that chloroquine treatment as a single agent increased the rodents' survival by 27 days compared with untreated control mice. This is encouraging, Kimmelman commented, because even the newest targeted drugs aimed at pancreatic cancer "don't have much effect in this genetic mouse model."

The Dana-Farber trial of hydroxychloroquine, led by Kimmelman and oncologist Brian Wolpin, MD, is designed to enroll 36 pancreatic cancer patients in whom first- or second-line treatments have failed. The drug is taken in pill form twice a day. Results won't become available for at least a year, said Kimmelman.

Kimmelman said the next step will be to investigate the combination of hydroxychloroquine with radiation in patients with operable pancreatic cancer.

"This is a very interesting and promising approach, attacking the Achilles' heel in pancreatic cancer's defenses," commented Robert Mayer, MD, of Dana-Farber's Center for Gastrointestinal Oncology. "But it's too early to say whether hydroxychloroquine should be added to chemotherapy, and what the risks and
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Malarias weakest link
2. New study shows ability of transgenic fungi to combat malaria and other bug-borne diseases
3. MIT engineers design new nanoparticle that could lead to vaccines for HIV, malaria, other diseases
4. Saint Louis U scientists partner on malaria research
5. UIC researcher unveils new approach to blocking malaria transmission
6. Substandard and counterfeit antimalarial drugs discovered in Ghana
7. New Malaria Drug Proves Effective in Study of African Children
8. Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide
9. Mosquito Evolution May Make It Harder to Fight Malaria: Study
10. Malaria-transmitting mosquito evolving, NIH grantees find
11. Scientists pinpoint gene linked to drug resistance in malaria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Malaria drug slows pancreatic cancer growth in mouse models
(Date:9/23/2014)... 23, 2014 Névo takes a bold ... timepiece and adding advanced activity tracking and phone notifications ... steps, distance, calories burned, and more. , http://www.nevowatch.com ... adopt healthy habits in their busy lives to look ... changes that produce healthy results, but until now, style ...
(Date:9/23/2014)... Texas (PRWEB) September 23, 2014 Dallas-based luxury ... the appointment of Leslie Eades as vice president of product ... brand as well as the primary lead on global sourcing ... the head of both the product development group and sourcing ... development team. , Eades notes, "Peacock Alley is a ...
(Date:9/23/2014)... Recently, BuyTopDress.com, a popular supplier of wedding dresses and special ... fashionable marine ball dresses . Along with this, the ... brand new items; all of them are now provided with ... now, BuyTopDress.com has won more than 2000 happy customers in ... its products and after-sale services. The company is offering thousands ...
(Date:9/22/2014)... 2014 Vida Cannabis Corp . ... Alliance Agreement with Florida-based AltMed LLC . ... assurance, and technical expertise. They’ll also pool business ... respective markets. , "We’re deeply impressed with the ... Vida Cannabis team as they work toward building the ...
(Date:9/22/2014)... 23, 2014 Career Step, an ... will be attending and exhibiting at the 86th ... Information Management Association (AHIMA) in San Diego, California. ... October 1, and Career Step will be exhibiting ... of coding training products, including CLiM™, its coder ...
Breaking Medicine News(10 mins):Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Luxury Linen Purveyor Peacock Alley Announces New Vice President of Product Development 2Health News:Fashionable Marine Ball Dresses Added To BuyTopDress.com’s Collection 2Health News:Vida Cannabis Allies with Florida Medical Cannabis Leader AltMed to Build Best-in-Class Expertise 2Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2
... International Retail Expansion, With Near Term Focus on Top ... ExtensionIRVINE, Calif., Jan. 21 University Medical ... and efficacy-based skin and beauty care products sold at ... U.S., announced today that it has appointed Tom Roche ...
... following statement can be attributed to Michael J. ... consistently said two things: We are not inherently ... we have urged public policy makers to think ... without conditions, because without conditions the merger would ...
... 21 Omnicell, Inc. (Nasdaq: OMCL ), a leading provider ... 29 to discuss the Company,s fourth quarter 2008 financial results. , ... webcast, ... Who: Randall Lipps, chairman, president and chief executive officer, ...
... (Nasdaq: IDXX ), has scheduled the release of ... January 30, at approximately 7:00 a.m. (eastern). The Company will ... on that day. Individuals can access a live Webcast of ... site, www.idexx.com . An archived edition of the call ...
... Carolina researchers say it could detect virus that can ... -- A new urine test that can detect a ... to better diagnosis and treatment of patients with polyomavirus ... patients. , Polyomaviruses are harmless to healthy adults ...
... -- Schizophrenia may blur the boundary between internal and ... involved in self-reflection, and thus causing an exaggerated focus ... study has found. , The traditional view of ... that characterize the disease are caused by disconnections among ...
Cached Medicine News:Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 2Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 3Health News:Capital Blue Cross Issues Statement on Withdrawal of Merger 2Health News:Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29 2Health News:New Test May Help Kidney Transplant Patients 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 3
(Date:9/22/2014)... and SHANGHAI , Sept. ... (BHG), a global knowledge leader in healthcare technology, ... to support healthcare innovation in China ... connected health technologies. Continua and BHG announced this ... being held this week in Washington, ...
(Date:9/22/2014)... , Sept. 22, 2014  Aethlon Medical, ... therapeutic devices to address infectious disease, cancer and ... Advanced Research Projects Agency (DARPA) has informed the ... to proceed with year four of a five-year ... on September 30, 2011 under DARPA,s Dialysis-Like Therapeutics ...
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3
... Calif., Oct. 25 Applied Seals North ... products used in ultraclean manufacturing of nanoelectronics and ... capabilities at its Silicon Valley headquarters with the ... Chen joins the company,s product engineering team to ...
... EAST BRUNSWICK, N.J., Oct. 25 Savient Pharmaceuticals, Inc. (Nasdaq: ... process to identify, following the approval of KRYSTEXXA™ by the ... the sale of the Company did not result in a ... directors will continue to evaluate strategic alternatives available to the ...
Cached Medicine Technology:Applied Seals North America Bolsters Engineering and Applications Services in Silicon Valley With Addition of Design Engineer 2Savient Pharmaceuticals Provides Update on Strategic Alternatives Process 2Savient Pharmaceuticals Provides Update on Strategic Alternatives Process 3
... The UrinQuick Urine Chemistry Analyzer is ... analysis of urine test strips. The UrinQuick ... for QuickVue UrinChek 10+ SG and QuickVue ... analyzes the urine test strips by reflectance ...
... a qualitative assay for rapid detection of Strep ... Strep A test excels at detection of Strep ... colonization samples. This CLIA Waived test uses a ... Strep A leaves little chance for misdiagnosis, minimizing ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
...
Medicine Products: